ANTIBACTERIAL ACTIVITY OF ANNONA MURICATA LEAF BIOFRACTIONS AGAINST PSEUDOMONAS AERUGINOSA ISOLATED FROM WOUND INFECTIONS

Authors

  • Ibukunoluwa, M.R.; Omobolade, O.; Omobolade, E.O.; Abadariki, O.O.; Amubieya, E.O. Author

Keywords:

Annona muricata; antimicrobial resistance; biofraction; disc diffusion; minimum inhibitory concentration; phytotherapy; Pseudomonas aeruginosa; wound infection

Abstract

Wound infections caused by drug-resistant Gram-negative bacteria constitute a major global health concern, with Pseudomonas aeruginosa recognized as a leading etiological agent due to its intrinsic and acquired resistance mechanisms. The burden of antimicrobial resistance (AMR) associated with this pathogen exceeds 300,000 deaths annually, highlighting the urgent need for alternative therapeutic approaches. This study investigated the antibacterial activity of solvent-partitioned biofractions of Annona muricata (soursop) leaves against clinical isolates of P. aeruginosa obtained from wound infections. Fresh leaves were pulverized, extracted with methanol, and subsequently partitioned sequentially using n-hexane, ethyl acetate, and methanol. Ten isolates were confirmed using standard biochemical tests, while antibiotic susceptibility was determined using the disc diffusion method following Clinical and Laboratory Standards Institute (CLSI) guidelines. The antibacterial activity of the biofractions was evaluated at concentrations ranging from 100–400 μg/mL, and minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined using the broth microdilution method. Ethyl acetate yielded the highest extract (49.64%), followed by methanol (46.52%) and n-hexane (3.84%). All isolates exhibited multidrug resistance, although ciprofloxacin and gentamicin showed comparatively higher effectiveness. Both ethyl acetate and methanol fractions demonstrated concentration dependent antibacterial activity, with the ethyl acetate fraction showing slightly superior efficacy. MIC values ranged from 300–400 μg/mL, while MBC values were predominantly 400 μg/mL, indicating bactericidal effects. These findings support the potential of A. muricata leaf biofractions as promising candidates for the development of plant-based antimicrobial agents against resistant wound pathogens.

References

Abba, I., & Oduola, T. (2023). Plant-derived antimicrobials as alternative therapy for multidrug-resistant bacteria. Frontiers in Microbiology, 14, Article 1134829. https://doi.org/10.3389/fmicb.2023.1134829

Abdul Wahab, S. M., Jantan, I., Haque, M. A., & Arshad, L. (2018). Exploring the leaves of Annona muricata L. as a source of potential anti-inflammatory and anticancer agents. Frontiers in Pharmacology, 9, Article 661. https://doi.org/10.3389/fphar.2018.00661

Adefioye, O. A., Ogunleye, V. F., Oladipo, O. O., & Okunlade, A. O. (2023). Prevalence and antimicrobial resistance profile of Pseudomonas aeruginosa in wound infections in Nigeria. South African Journal of Infectious Diseases, 38(1), e1–e7. https://doi.org/10.4102/sajid.v38i1.490

Aguilar-Hernández, G., López-Romero, B. A., Pérez-Larios, A., Ruvalcaba-Gómez, J. M., Castellanos-Huerta, I., Tellez-Isaias, G., & Montalvo-González, E. (2022). Antibacterial activity of crude extract and purified acetogenins from Annona muricata seeds. Applied Sciences, 13(1), Article 558. https://doi.org/10.3390/app13010558

Aguilar-Hernández, G., López-Romero, B. A., Huerta-Castellanos, I., Tellez-Isaias, G., & Montalvo-González, E. (2024). Acetogenins from Annona muricata as antimicrobial agents. In Enterococcus—Unveiling the emergence of a potent pathogen. IntechOpen. https://doi.org/10.5772/intechopen.115064

Akinmoladun, F. O., Komolafe, T. R., Farombi, O. E., & Oyedapo, O. O. (2020). Ethnobotanical survey and phytochemical screening of Annona muricata Linn. used in Southwestern Nigeria. Journal of Ethnopharmacology, 259, Article 112950. https://doi.org/10.1016/j.jep.2020.112950

Al-Daghistani, H. I., Abu-Niaaj, L. F., & Zein, S. (2025). Accurate diagnosis of Pseudomonas aeruginosa is critical to mitigating development of antibiotic resistance. Antibiotics, 14(5), Article 509. https://doi.org/10.3390/antibiotics14050509

Appiah, T., Boakye, Y. D., & Agyare, C. (2017). Antimicrobial activities and time-kill kinetics of extracts of selected Ghanaian mushrooms. Evidence-Based Complementary and Alternative Medicine, 2017, Article 4534350. https://doi.org/10.1155/2017/4534350

Ashagrie, G., Abebe, A., & Umer, S. (2023). Analgesic and anti-inflammatory activities of 80% methanol extract and solvent fractions of Ehretia cymosa Thonn (Boraginaceae) leaves in rodents. Journal of Experimental Pharmacology, 15, 63–79. https://doi.org/10.2147/JEP.S396769

Awanye, A. M., Ibezim, C. N., Stanley, C. N., Onah, H., Okonko, I. O., & Egbe, N. E. (2022). Multidrug-resistant and extremely drug-resistant Pseudomonas aeruginosa in clinical samples from a tertiary healthcare facility in Nigeria. Turkish Journal of Pharmaceutical Sciences, 19(4), 447–454. https://doi.org/10.4274/tjps.galenos.2021.66066

Bandy, A., Wani, F. A., Mohammed, A. H., Dar, U. F., Mallick, A., Dar, M. R., & Tantry, B. A. (2022). Bacteriological profile of wound infections and antimicrobial resistance in selected gram-negative bacteria. African Health Sciences, 22(4), 576–586. https://doi.org/10.4314/ahs.v22i4.63

Bushirat, F. O., Adewuyi, H. A., Adio, S. W., Musa, M. N., Olusegun, T. G., Ishola, A. B., Idoko, A., Kolawole, A. V., Oluwatuyi, A. A., & Agwasim, S. N. (2025). Phytochemical analysis, antioxidant, and antibacterial properties of partition fractions of Adansonia digitata and Annona muricata extracts using chloroform, ethyl acetate, ethanol, and aqueous solvent systems. Journal of Biomedical and Clinical Research, 18, 199–213. https://doi.org/10.3897/jbcr.e142717

Chang, W. C., Turner, A., Imon, M., & Dyda, A. (2016). Patient risk factors for mechanical wound complications and postoperative infections after elective open intestinal resection. International Journal of Health Sciences, 10(4), 468–479.

Cheesbrough, M. (2016). District laboratory practice in tropical countries (Part 2, 2nd ed.). Cambridge University Press. http://dx.doi.org/10.1017/CBO9781139103470

Clinical and Laboratory Standards Institute. (2023). Performance standards for antimicrobial susceptibility testing (33rd ed.; CLSI Supplement M100). Clinical and Laboratory Standards Institute.

Coria-Téllez, A. V., Montalvo-González, E., Yahia, E. M., & Obledo-Vázquez, E. N. (2018). Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity. Arabian Journal of Chemistry, 11(5), 662–691. https://doi.org/10.1016/j.arabjc.2016.01.004

Dey, S. S., Al Bashera, M., Moulick, S. P., Ahmed, F., Sadiq, M. Z. A., Yeasmin, M. S., & Sarkar, M. M. H. (2025). Comparative analysis of four different solvent extracts of Annona muricata bark based on bioactive compounds and antibacterial effectiveness. Heliyon, 11(4), Article e42516. https://doi.org/10.1016/j.heliyon.2025.e42516

Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., & Nageeb, W. M. (2024). Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Frontiers in Microbiology, 15, Article 1374466. https://doi.org/10.3389/fmicb.2024.1374466

Ezeador, C. O., Ejikeugwu, P. C., Ushie, S. N., & Agbakoba, N. R. (2020). Isolation, identification and prevalence of Pseudomonas aeruginosa isolates from clinical and environmental sources in Onitsha Metropolis, Anambra State. European Journal of Medical and Health Sciences, 2(2). https://doi.org/10.24018/ejmed.2020.2.2.188

Frem, J. A., Doumat, G., Kazma, J., Gharamti, A., Kanj, S. S., Abou Fayad, A. G., Matar, G. M., & Kanafani, Z. A. (2023). Clinical predictors of mortality in patients with Pseudomonas aeruginosa infection. PLOS ONE, 18(4), Article e0282276. https://doi.org/10.1371/journal.pone.0282276

George, V. C., Kumar, D. R. N., Rajkumar, V., Suresh, P. K., & Ashok Kumar, R. (2012). Quantitative assessment of the relative antineoplastic potential of the n-butanolic leaf extract of Annona muricata Linn. in normal and immortalized human cell lines. Asian Pacific Journal of Cancer Prevention, 13(2), 699–704. https://doi.org/10.7314/APJCP.2012.13.2.699

Hancock, R. E., & Speert, D. P. (2022). Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and impact on treatment. Clinical Microbiology Reviews, 35(2), Article e0002221. https://doi.org/10.1128/CMR.00022-21

Haque, M. D., Jantan, I., & Harikrishnan, H. (2018). Exploring the leaves of Annona muricata L. as a source of potential anti-inflammatory and anticancer agents. Frontiers in Pharmacology, 9, Article 661. https://doi.org/10.3389/fphar.2018.00661

Isaac, J. U., Tyem, L. D., Katchim, E. S., & Kerenhappuch, I. U. (2025). Phytochemical, nutraceutical profiles and potential of soursop leaf extract (Annona muricata) on bacterial meningitis. African Journal of Medical, Surgical and Public Health Research, 3(1), 78–97. https://doi.org/10.58578/ajmsphr.v3i1.8300

Kazaure, A. A., Sani, A. M., & Dan, V. M. (2024). Phytochemicals and antibacterial efficacy of Annona muricata (soursop) stem bark and leaf extracts against some clinical bacterial isolates. Science World Journal, 20(1), 214–222. https://doi.org/10.4314/swj.v20i1.28

Kottila, R., & Hena, J. V. (2024). Phytochemical properties and therapeutic applications of Annona muricata: A comprehensive review. Journal of Young Pharmacists, 16(4), 642–652. https://doi.org/10.5530/jyp.2024.16.82

Kristiningrum, N., Amaliyah, E. A., & Pratoko, D. K. (2020). Phytochemical screening, antioxidant and antibacterial activities of ethanol extract and fractions of Aleurites moluccana (L.) Willd. leaves. Tropical Journal of Natural Product Research, 4(11), 895–898. https://doi.org/10.26538/tjnpr/v4i11.9

Kumari, A., Singh, R., & Tripathi, A. (2025). The ethnobotanical and pharmacological efficacy of Annona muricata extracts and decoctions. International Journal of Fundamental and Applied Sciences, 14(2), 4– 15.

Laborda, P., Sanz-Garcia, F., Hernando-Amado, S., & Martínez, J. L. (2021). Pseudomonas aeruginosa: An antibiotic resilient pathogen with environmental origin. Current Opinion in Microbiology, 64, 125–132. https://doi.org/10.1016/j.mib.2021.09.010

Lorusso, A. B., Carrara, J. A., Barroso, C. D. N., Tuon, F. F., & Faoro, H. (2022). Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa. International Journal of Molecular Sciences, 23(24), Article 15779. https://doi.org/10.3390/ijms232415779

Mishra, A. P., Yalo, M., Nambooze, J., Pohl, C. H., Kemp, G., Setsiba, L. K., & Matsabisa, M. G. (2025). Characterization and enhanced antibiofilm activity of Annona muricata extract in combination with fluconazole against Candida albicans. Drug Target Insights, 19, 1–10 https://doi.org/10.33393/dti.2025.3171

Moghadamtousi, S. Z., Fadaeinasab, M., Nikzad, S., Mohan, G., Ali, H. M., & Kadir, H. A. (2015). Annona muricata (Annonaceae): A review of its traditional uses, isolated acetogenins and biological activities. International Journal of Molecular Sciences, 16(7), 15625–15658. https://doi.org/10.3390/ijms160715625

Mutakin, M., Fauziati, R., Fadhilah, F. N., Zuhrotun, A., Amalia, R., & Hadisaputri, Y. E. (2022). Pharmacological activities of soursop (Annona muricata Lin.). Molecules, 27(4), Article 1201. https://doi.org/10.3390/molecules27041201

Nawaz, H., Akram, H., Ishaq, Q. H. M., Khalid, A., Zainab, B., & Mazhar, A. (2022). Polarity-dependent response of phytochemical extraction and antioxidant potential of different parts of Alcea rosea. Free Radical Biology and Medicine, 179, 1–10. https://doi.org/10.1016/j.freeradbiomed.2021.12.248

Nolasco-González, Y., Chacón-López, M. A., Ortiz-Basurto, R. I., Aguilera-Aguirre, S., González-Aguilar, G. A., Rodríguez-Aguayo, C., & Montalvo-González, E. (2022). Annona muricata leaves as a source of bioactive compounds: Extraction and quantification using ultrasound. Horticulturae, 8(7), Article 560. https://doi.org/10.3390/horticulturae8070560

Nwonuma, C. O., Balogun, E. A., & Gyebi, G. A. (2023). Evaluation of antimalarial activity of ethanolic extract of Annona muricata L.: An in vivo and an in-silico approach. Journal of Evidence-Based Integrative Medicine, 28, Article 2515690X231165104. https://doi.org/10.1177/2515690X231165104

Ojo, S. K. S., Esumeh, F. I., Osanyinlusi, S. A., & Jeje, O. O. (2017). Phytochemical and antibacterial properties of Diodia scandens and Phyllanthus amarus on staphylococci isolated from patients in tertiary hospitals in Nigeria. Journal of Medicinal Plants Economics and Development, 1(1), Article a7. https://doi.org/10.4102/jomped.v1i1.7

Oliver, A., Rojo-Molinero, E., Arca-Suarez, J., Beşli, Y., Bogaerts, P., Cantón, R., Cimen, C., Croughs, P. D., Denis, O., Giske, C. G., Graells, T., Huang, T. D., Iorga, B. I., Karatuna, O., Kocsis, B., Kronenberg, A., López-Causapé, C., Malhotra-Kumar, S., Martínez Martínez, L., & Jeannot, K. (2024). Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages:

Update from ESGARS-ESCMID/ISARPAE Group. Clinical Microbiology and Infection, 30(4), 469–480. https://doi.org/10.1016/j.cmi.2023.12.026

Pang, Z., Raudonis, R., Glick, B. R., Lin, T. J., & Cheng, Z. (2019). Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnology Advances, 37(1), 177– 192. https://doi.org/10.1016/j.biotechadv.2018.11.013

Sari, I., Hakim, M., Setiawan, A., & Montalvo-González, E. (2025). Extraction techniques and optimization strategies for phytochemicals from Annona muricata leaf: A comprehensive review (2010–2024). International Journal of Agriculture and Biology, 34, 1–18. https://doi.org/10.17957/IJAB/15.2025

Tahir, M. F., Mughal, S., Nadeem, A., Khan, M., Hannat, R., & Jaber Amin, M. H. (2025). Reducing the burden of surgical site infections in low and middle-income countries: Challenges and recommendations. Annals of Medicine and Surgery, 87(8), 5335–5337. https://doi.org/10.1097/MS9.0000000000003473

Vidal-Cortés, P., Campos-Fernández, S., Cuenca-Fito, E., del Río-Carbajo, L., Fernández-Ugidos, P., LópezCiudad, V. J., Nieto-del Olmo, J., Rodríguez-Vázquez, A., & Tizón Varela, A. I. (2025). Difficult-totreat Pseudomonas aeruginosa infections in critically ill patients: A comprehensive review and treatment proposal. Antibiotics, 14(2), Article 178. https://doi.org/10.3390/antibiotics14020178

Wilkie, E. D., Michael, P. O., Oluduro, A. O., & Alao, J. O. (2023). Antibacterial potential of Annona muricata (Linn.) leaf extract: A promising natural source for novel antibacterial therapies. South Asian Journal of Research in Microbiology, 16(1), 34–44. https://doi.org/10.9734/sajrm/2023/v16i1384

World Health Organization. (2021). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibioticsare-urgently-needed

Wu, W., Huang, J., & Xu, Z. (2024). Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications. Microbial Biotechnology, 17(5), Article e14487. https://doi.org/10.1111/1751- 7915.14487

Zhen, S., Zhao, Y., Chen, Z., Zhang, T., Wang, J., Jiang, E., Zhang, F., Mi, Y., Zhu, X., Han, M., & Xiao, Z. (2023). Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases. Frontiers in Cellular and Infection Microbiology, 13, Article 1156651. https://doi.org/10.3389/fcimb.2023.1156651

Downloads

Published

2026-07-30